NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Harnessing Optimism and Perseverance in the Face of Long COVID-Español

Not Yet RecruitingNA

Sponsor: Icahn School of Medicine at Mount Sinai

Conditions: Post-Acute COVID-19 Syndrome

Interventions: HOPE-LC~Espanol

Countries: United States

The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC\~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age 18 years or older.
* Speaks and understands Spanish at a level that allows active participation in group-based study procedures.
* Self-reported history of Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms affecting daily functioning or a medical professional has diagnosed you with a Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms.
* Ability to participate in group sessions either in-person or via telehealth (Zoom).
* Willingness and capacity to provide informed consent.

Exclusion Criteria:

* Presence of severe psychiatric conditions that would preclude participation in group therapy (e.g., active psychosis, suicidal intent requiring immediate intervention).
* Inability to communicate in Spanish sufficiently to engage meaningfully in group sessions.
* Cognitive or physical impairments prevent participation in group sessions or completion of surveys, without available accommodations.
* Concurrent participation in another conflicting interventional trial targeting Long COVID symptoms.

Locations (1)

New York, New York, United States